Royal Vopak (VOPKY)
(Delayed Data from OTC)
$47.51 USD
+0.78 (1.67%)
Updated Aug 23, 2024 03:49 PM ET
1-Strong Buy of 5 1
C Value C Growth B Momentum C VGM
Income Statements
Fiscal Year end for Royal Vopak falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,643 | 1,508 | 1,501 | 1,428 | 1,713 |
Cost Of Goods | 411 | 384 | 405 | 378 | 389 |
Gross Profit | 1,232 | 1,123 | 1,096 | 1,050 | 1,324 |
Selling & Adminstrative & Depr. & Amort Expenses | 739 | 733 | 731 | 640 | 648 |
Income After Depreciation & Amortization | 493 | 390 | 365 | 410 | 676 |
Non-Operating Income | 267 | -294 | 126 | 157 | 172 |
Interest Expense | 151 | 135 | 133 | 105 | 106 |
Pretax Income | 609 | -39 | 359 | 461 | 742 |
Income Taxes | 80 | 107 | 71 | 84 | 65 |
Minority Interest | 36 | 32 | 34 | 34 | 37 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 529 | -145 | 288 | 378 | 676 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 493 | -177 | 253 | 344 | 640 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 843 | 749 | 757 | 752 | 1,001 |
Depreciation & Amortization (Cash Flow) | 350 | 358 | 393 | 342 | 326 |
Income After Depreciation & Amortization | 493 | 390 | 365 | 410 | 676 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 125.88 | 125.67 | NA | 126.43 | 127.74 |
Diluted EPS Before Non-Recurring Items | 3.55 | 2.48 | NA | 2.76 | 3.14 |
Diluted Net EPS (GAAP) | 3.92 | -1.41 | 2.01 | 2.72 | 5.01 |
Fiscal Year end for Royal Vopak falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 350.37 | 356.34 | 379.89 | 383.11 | 390.80 |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | 114.85 | 114.87 | 94.11 | 156.94 | 131.72 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 114.85 | 114.87 | 94.11 | 156.94 | 131.72 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 121.25 | 124.47 | 126.67 | 125.39 | 124.74 |
Diluted EPS Before Non-Recurring Items | 1.08 | 0.92 | 0.94 | 0.84 | 0.91 |
Diluted Net EPS (GAAP) | 0.95 | 0.92 | 0.74 | 1.25 | 1.06 |